NextCell Pharma AB (OSTO:NXTCL) EV-to-Revenue : 1.58 (As of May. 26, 2024)

NextCell Pharma AB EV-to-Revenue Chart

NextCell Pharma AB Annual Data
	Trend	Aug15	Aug16	Aug17	Aug18	Aug19	Aug20	Aug21	Aug22	Aug23
EV-to-Revenue		Get a 7-Day Free Trial				47.04	63.08	91.85	21.68	7.29

NextCell Pharma AB Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EV-to-Revenue	Get a 7-Day Free Trial															22.75	11.93	7.29	5.47	4.93

Competitive Comparison of NextCell Pharma AB's EV-to-Revenue

For the Biotechnology subindustry, NextCell Pharma AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NextCell Pharma AB's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NextCell Pharma AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where NextCell Pharma AB's EV-to-Revenue falls into.

NextCell Pharma AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

NextCell Pharma AB's EV-to-Revenue for today is calculated as:

NextCell Pharma AB's current Enterprise Value is kr19.63 Mil.
NextCell Pharma AB's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr12.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NextCell Pharma AB  (OSTO:NXTCL) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

NextCell Pharma AB's PS Ratiofor today is calculated as:

NextCell Pharma AB's share price for today is kr1.455.
NextCell Pharma AB's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.36.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NextCell Pharma AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

NextCell Pharma AB (OSTO:NXTCL) Business Description